FXR1 and neoplasm: CD4+ T cells in the blood and spleen of mice recovered after cDHPs administration and CD4+ T cells in the tumor microenvironment were converted to suppressive iTr35 cells by the FXR1-IL-35 axis, while NK cells showed increased viability after treatment, confirming the previous conjecture that the anti-tumor immune effect of the organism was enhanced.